The Pharmacological Effects of Using Cabozantinib With a Light Breakfast

Clinical trial NCT05263245 · COMPLETED

Trial details

NCT number: NCT05263245
Sponsor: dr. Tom van der Hulle
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2023-05-25
Primary completion: 2025-03-11
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.